Combination of rituximab and nonpegylated liposomal doxorubicin (R‐NPLD) as front‐line therapy for aggressive non‐Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single‐center retrospective study
暂无分享,去创建一个
F. Angrilli | M. Federico | S. Luciani | M. Di Nicola | I. A. L. Zecca | E. Finolezzi | Elena Ranucci | G. Ricciuti | E. Ranucci